Filing Details

Accession Number:
0001437749-21-011553
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-10 13:00:00
Reporting Period:
2021-05-06
Accepted Time:
2021-05-10 17:05:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
72444 Vaxart Inc. VXRT Biological Products, (No Disgnostic Substances) (2836) 591212264
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652203 Wouter Latour C/O Vaxart, Inc.
170 Harbor Way, Suite 300
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-06 100,000 $1.70 100,000 No 4 M Direct
Common Stock Disposition 2021-05-06 100,000 $6.54 0 No 4 S Direct
Common Stock Acquisiton 2021-05-07 100,000 $1.70 100,000 No 4 M Direct
Common Stock Disposition 2021-05-07 100,000 $7.13 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-05-06 100,000 $0.00 100,000 $1.70
Common Stock Stock Option (right to buy) Disposition 2021-05-07 100,000 $0.00 100,000 $1.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
800,000 2030-03-23 No 4 M Direct
700,000 2030-03-23 No 4 M Direct
Footnotes
  1. 31.25% of the shares subject to this stock option vested on June 8, 2020, the grant date, with the remaining 68.75% vesting in 22 equal monthly installments on the first day of each calendar month thereafter, such that the option shall be fully vested on April 1, 2022.